BIOMAT Database Logo BIOMAT Database Logo

Real-time quantitation of bcr-abl transcripts in haematological malignancies. 2000

R Saffroy, and A Lemoine, and P Brézillon, and N Frénoy, and B Delmas, and E Goldschmidt, and B Souleau, and G Nedellec, and B Debuire
Service de Biochimie et Biologie moléculaire-UPRES-EA 1596, Hôpital Paul Brousse and Faculté de Médecine Paris Sud Université Paris XI, Villejuif, France.

We have applied an automated real-time quantitative PCR assay using a double-labeled fluorogenic probe to detect t(9;22)-positive cells in haematological malignancies. The results are expressed as the ratio of chimeric bcr-abl transcripts on abl transcripts. Highly reproducible results were obtained for t(9;22)-positive K562 RNA. Ten copies of bcr-abl DNA from a recombinant KW-3 plasmid and one positive cell in 10(4) can be detected. Thirty-two patients with chronic myeloid leukaemia (CML), 25 with acute leukaemia, 12 with myelodysplastic syndromes and 7 with other myeloproliferative syndromes were tested. Follow-up data were obtained in bcr-abl positive cases. Results were compared with those of conventional nested RT-PCR and cytogenetics. Real-time quantitative RT-PCR values correlated well with both these methods. However, in some cases the only means of detecting early relapse or blastic transformation was to examine the kinetics of real-time quantitative RT-PCR. Thus, real-time quantitative RT-PCR appears suitable for the diagnosis and follow-up of patients with the t(9;22) translocation.

UI MeSH Term Description Entries
D007951 Leukemia, Myeloid Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites. Granulocytic Leukemia,Leukemia, Granulocytic,Leukemia, Myelocytic,Leukemia, Myelogenous,Myelocytic Leukemia,Myelogenous Leukemia,Myeloid Leukemia,Leukemia, Monocytic, Chronic,Monocytic Leukemia, Chronic,Chronic Monocytic Leukemia,Chronic Monocytic Leukemias,Granulocytic Leukemias,Leukemia, Chronic Monocytic,Leukemias, Chronic Monocytic,Leukemias, Granulocytic,Leukemias, Myelocytic,Leukemias, Myelogenous,Leukemias, Myeloid,Monocytic Leukemias, Chronic,Myelocytic Leukemias,Myelogenous Leukemias,Myeloid Leukemias
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D008297 Male Males
D009190 Myelodysplastic Syndromes Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA. Dysmyelopoietic Syndromes,Hematopoetic Myelodysplasia,Dysmyelopoietic Syndrome,Hematopoetic Myelodysplasias,Myelodysplasia, Hematopoetic,Myelodysplasias, Hematopoetic,Myelodysplastic Syndrome,Syndrome, Dysmyelopoietic,Syndrome, Myelodysplastic,Syndromes, Dysmyelopoietic,Syndromes, Myelodysplastic
D010677 Philadelphia Chromosome An aberrant form of human CHROMOSOME 22 characterized by translocation of the distal end of chromosome 9 from 9q34, to the long arm of chromosome 22 at 22q11. It is present in the bone marrow cells of 80 to 90 per cent of patients with chronic myelocytic leukemia (LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE). Ph1 Chromosome,Ph 1 Chromosome,1 Chromosomes, Ph,Chromosome, Ph 1,Chromosome, Ph1,Chromosome, Philadelphia,Chromosomes, Ph 1,Chromosomes, Ph1,Ph 1 Chromosomes,Ph1 Chromosomes
D012015 Reference Standards A basis of value established for the measure of quantity, weight, extent or quality, e.g. weight standards, standard solutions, methods, techniques, and procedures used in diagnosis and therapy. Standard Preparations,Standards, Reference,Preparations, Standard,Standardization,Standards,Preparation, Standard,Reference Standard,Standard Preparation,Standard, Reference
D001854 Bone Marrow Cells Cells contained in the bone marrow including fat cells (see ADIPOCYTES); STROMAL CELLS; MEGAKARYOCYTES; and the immediate precursors of most blood cells. Bone Marrow Cell,Cell, Bone Marrow,Cells, Bone Marrow,Marrow Cell, Bone,Marrow Cells, Bone
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R Saffroy, and A Lemoine, and P Brézillon, and N Frénoy, and B Delmas, and E Goldschmidt, and B Souleau, and G Nedellec, and B Debuire
Quantitative measurement of BCR/abl transcripts using real-time polymerase chain reaction.
May 2002, Annals of oncology : official journal of the European Society for Medical Oncology,
R Saffroy, and A Lemoine, and P Brézillon, and N Frénoy, and B Delmas, and E Goldschmidt, and B Souleau, and G Nedellec, and B Debuire
LightCycler technology for the quantitation of bcr/abl fusion transcripts.
July 1999, Cancer research,
R Saffroy, and A Lemoine, and P Brézillon, and N Frénoy, and B Delmas, and E Goldschmidt, and B Souleau, and G Nedellec, and B Debuire
Real-time quantification for BCR-ABL transcripts in chronic myeloid leukaemia patients in UKMMC, Malaysia.
December 2011, The Malaysian journal of pathology,
R Saffroy, and A Lemoine, and P Brézillon, and N Frénoy, and B Delmas, and E Goldschmidt, and B Souleau, and G Nedellec, and B Debuire
Detection of BCR-ABL transcripts by multiplex and nested PCR in different haematological disorders.
March 2000, Leukemia & lymphoma,
R Saffroy, and A Lemoine, and P Brézillon, and N Frénoy, and B Delmas, and E Goldschmidt, and B Souleau, and G Nedellec, and B Debuire
[Application of Real-time Quantitative PCR in Detecting Atypical BCR/ABL mRNA Transcripts in Chronic Myelocytic Leukemia].
August 2017, Zhongguo shi yan xue ye xue za zhi,
R Saffroy, and A Lemoine, and P Brézillon, and N Frénoy, and B Delmas, and E Goldschmidt, and B Souleau, and G Nedellec, and B Debuire
Detection of BCR-ABL transcripts in chronic myeloid leukemia (CML) using a 'real time' quantitative RT-PCR assay.
June 1999, Leukemia,
R Saffroy, and A Lemoine, and P Brézillon, and N Frénoy, and B Delmas, and E Goldschmidt, and B Souleau, and G Nedellec, and B Debuire
Analysis of BCR/ABL transcripts in healthy individuals.
October 2013, Genetics and molecular research : GMR,
R Saffroy, and A Lemoine, and P Brézillon, and N Frénoy, and B Delmas, and E Goldschmidt, and B Souleau, and G Nedellec, and B Debuire
Alternative BCR/ABL transcripts in chronic myeloid leukemia.
October 1990, Blood,
R Saffroy, and A Lemoine, and P Brézillon, and N Frénoy, and B Delmas, and E Goldschmidt, and B Souleau, and G Nedellec, and B Debuire
Residual bcr/abl transcripts in chronic myeloid leukaemia.
February 1990, Lancet (London, England),
R Saffroy, and A Lemoine, and P Brézillon, and N Frénoy, and B Delmas, and E Goldschmidt, and B Souleau, and G Nedellec, and B Debuire
[Importance of quantitative evaluation of BCR-ABL transcripts using real-time PCR for effective treatment of chronic myeloid leukemia].
January 2006, Casopis lekaru ceskych,
Copied contents to your clipboard!